Anondita Medicare IPO Subscription Day 2

Here is the final call for the Anondita Medicare IPO launched on 22nd August 2025. The issue will be closed for bidding today, on 26th August 2025. The primary aim of the Anondita Medicare IPO is to raise ₹69.50 crores from the market. Also, the Anondita Medicare IPO has received an impressive level of subscription, which indicates that shares will be listed at an impeccable premium. Scroll down to check the Anondita Medicare IPO subscription and details. 

Anondita Medicare IPO Details

The price band for the Anondita Medicare has been prescribed as ₹137 to ₹145 per share, and 47,93,000 shares in total have been issued. Let’s segregate the share quota fixed for different categories of investors. 

Anondita Medicare IPO Subscription Status

As of now, the Anondita Medicare IPO has been subscribed 40.87 times. Of these, 56.16 times are subscribed by retail investors, 56.73 times by non-institutional investors, and 2.17 times by QII (Qualified Institutional Investors).  

The healthy subscription status indicates that investors are expecting higher returns at the time of the Anondita Medicare IPO listing on 1st September 2025. Anondita Medicare IPO also has a positive outlook behind the fresh issue of 0.48 crore shares to raise around Rs 69.50 crores.

Anondita Medicare IPO GMP Today

We know that higher subscriptions encourage grey market premiums for the IPOs. Let’s explore the Anondita Medicare IPO GMP for 25th August 2025. 

The grey market premium for this IPO is 48.28% or Rs 70 per share. It indicates that the estimated listing price per share is Rs 215. Numerous factors played a pivotal role in this jump in the IPO GMP of Anondita Medicare. These include higher subscriptions received, positive market sentiments, and investors’ positive attitude towards IPO. 

About Anondita Medicare Limited

Anondita Medicare Limited was incorporated in March 2024. It is engaged in the manufacturing of male condoms under its brand as COBRA. They have gained experience in the industry and supplied their products to pharma companies. Anondita Medicare Limited has partnered with global health organisations and NGOs, and is also backed by government support.

Anondita Medicare Limited Financials

The company’s financial analysis is essential before applying for the Anondita Medicare IPO. Look at the table to learn about Anondita Medicare Limited’s financials. 

Explanation

Anondita Medicare Limited’s revenue increased by 66% from ₹46.56 crores in March 2024 to ₹77.13 crores in March 2025. Moreover, the company’s PAT rose by 327% from ₹3.84  crores to ₹16.42 crores.

Technical Analysis

Several technical indicators are available to assess a company’s potential to deliver returns. Use the parameters mentioned below to analyse the technical aspects of the Anondita Medicare IPO.

Anondita Medicare IPO Listing Expectations 

Anondita Medicare IPO Highlights: IPO allotment is still pending, as the bid will be closed today. However, as per the current GMP or market sentiments, it is appropriate to expect higher listing gains from the share. A jump of 48.28% in Anondita Medicare IPO GMP indicates that the estimated listing price per share will be somewhere around Rs 215.

It will provide higher listing gains to investors who applied for this IPO. Also, the financial fundamentals of this business made it the experts’ best recommendations for the long term.

Anondita Medicare IPO Timeline

Note: IPO GMP is volatile based on market sentiment. Hence, one should conduct their research before investing in it.

Recent Articles

Current Infraprojects IPO GMP & Review: Apply or Avoid?

Sattva Engineering Construction IPO GMP & Review: Apply or Avoid?

Anlon Healthcare IPO GMP & Review: Apply or Avoid?

Vikran Engineering IPO GMP & Review: Apply or Avoid?

ARC Insulation & Insulators IPO GMP: Day 3 IPO Live Updates

Relative Strength Index | Everything You Should Know About

PhysicsWallah IPO Details: Everything You Should Know about

Studio LSD  IPO Listing Preview: What to Expect Now?